财联社9月20日电,诺和诺德预计针对肥胖症的Monlunabant 2B期更大规模试验,其表示2B期试验预计将于2025年启动。
“特别声明:以上作品内容(包括在内的视频、图片或音频)为凤凰网旗下自媒体平台“大风号”用户上传并发布,本平台仅提供信息存储空间服务。
Notice: The content above (including the videos, pictures and audios if any) is uploaded and posted by the user of Dafeng Hao, which is a social media platform and merely provides information storage space services.”